[Mandibular advancement devices in the treatment of obstructive sleep apnea].
Obstructive sleep apnea (OSA) affects approximately 450,000 people in Poland. Use of nasal continuous positive airway pressure (nCPAP) devices and laryngeal surgery are widely accepted OSA treatment methods. In 1995 ASDA approved oral devices for treatment of OSA patients. The aim of the study was to determine efficiency of mandibular advancement devices (MAD) in OSA therapy.


METHODS
The study group included 20 patients with OSA, all of whom did not tolerate nCPAP and did not have indications or did not agree for surgical treatment.


RESULTS
Control polysomnography was carried out in 11 patients using MAD. In 64% of patients AHI was lower then 10. No correlation between MAD use and AHI values was found. 45% of patients declared improvement of sleep quality and life comfort.


CONCLUSIONS
Use of mandibular advancement devices is an important alternative therapy of OSA.
Korczyński
Piotr
P
Klinika Chorób Wewnetrznych Pneumonologii i Alergologii Akademii Medycznej w Warszawie. pkorczyn@amwaw.edu.pl
Górska
Katarzyna
K
Wilk
Krzysztof
K
Bielicki
Piotr
P
Byśkiniewicz
Krzysztof
K
Baczkowski
Tadeusz
T
D000328:Adult; D000368:Aged; D015992:Body Mass Index; D045422:Continuous Positive Airway Pressure / Q000295:instrumentation; D004867:Equipment Design; D005260:Female; D006801:Humans; D008297:Male; D019186:Mandibular Advancement / Q000295:instrumentation*; D008875:Middle Aged; D020181:Sleep Apnea, Obstructive / Q000628:therapy*